These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29803532)

  • 1. Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study.
    Marshall JK; Bessette L; Shear NH; Lebovic G; Glass J; Millson B; Gaetano T; Gazel S; Latour MG; Laliberté MC; Thorne JC
    Clin Ther; 2018 Jun; 40(6):1024-1032. PubMed ID: 29803532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study.
    Marshall JK; Bessette L; Thorne C; Shear NH; Lebovic G; Gerega SK; Millson B; Oraichi D; Gaetano T; Gazel S; Latour MG; Laliberté MC
    Clin Ther; 2018 Mar; 40(3):415-429.e6. PubMed ID: 29519714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
    J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit.
    Fendrick AM; Brixner D; Rubin DT; Mease P; Liu H; Davis M; Mittal M
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1086-1095. PubMed ID: 33843252
    [No Abstract]   [Full Text] [Related]  

  • 5. Is Patient Support Program Participation Associated with Longer Persistence and Improved Adherence Among New Users of Adalimumab? A Retrospective Cohort Study.
    Srulovici E; Garg V; Ghilai A; Feldman B; Hoshen M; Balicer RD; Skup M; Leventer-Roberts M
    Adv Ther; 2018 May; 35(5):655-665. PubMed ID: 29748914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study.
    van der Have M; Oldenburg B; Kaptein AA; Jansen JM; Scheffer RC; van Tuyl BA; van der Meulen-de Jong AE; Pierik M; Siersema PD; van Oijen MG; Fidder HH
    J Crohns Colitis; 2016 May; 10(5):549-55. PubMed ID: 26738757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
    Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: An analysis of the South Korean National Health Insurance Database.
    Lee MY; Shin JY; Park SY; Kim D; Cha HS; Lee EK
    Semin Arthritis Rheum; 2018 Feb; 47(4):485-491. PubMed ID: 28939234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
    Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J
    J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions.
    Calip GS; Adimadhyam S; Xing S; Rincon JC; Lee WJ; Anguiano RH
    Semin Arthritis Rheum; 2017 Oct; 47(2):157-164. PubMed ID: 28410817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab persistence for inflammatory bowel disease in veteran and insured cohorts.
    Govani SM; Lipson R; Noureldin M; Wiitala W; Higgins PDR; Saini SD; Pugh JA; Velligan DI; Stidham RW; Waljee AK
    Am J Manag Care; 2018 Dec; 24(12):e374-e379. PubMed ID: 30586485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of adherence and persistence profile in a real-life population of patients treated with adalimumab.
    Gendelman O; Weitzman D; Rosenberg V; Shalev V; Chodick G; Amital H
    Br J Clin Pharmacol; 2018 Apr; 84(4):786-795. PubMed ID: 29272556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study.
    Bessette L; Lebovic G; Millson B; Charland K; Donepudi K; Gaetano T; Remple V; Latour MG; Gazel S; Laliberté MC; Thorne C
    Rheumatol Ther; 2018 Jun; 5(1):75-85. PubMed ID: 29633196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Adalimumab Patient Support Program's Care Coach Calls on Clinical Outcomes in Patients with Crohn's Disease in Canada: An Observational Retrospective Cohort Study.
    Narula N; Millson B; Charland K; Donepudi K; Gaetano T; McHugh K; Latour MG; Gazel S; Laliberté MC; Marshall JK
    J Can Assoc Gastroenterol; 2018 Dec; 1(4):191-198. PubMed ID: 31294360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence and persistence in the treatment of rheumatoid arthritis with adalimumab and etanercept. Six years of analysis.
    Santoleri F; Sorice P; Lasala R; Rizzo RC; Costantini A
    J Med Econ; 2014 May; 17(5):320-5. PubMed ID: 24641160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus.
    Farr AM; Sheehan JJ; Curkendall SM; Smith DM; Johnston SS; Kalsekar I
    Adv Ther; 2014 Dec; 31(12):1287-305. PubMed ID: 25504156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence and attrition to biologic treatment in rheumatoid arthritis patients.
    Chu LH; Kawatkar AA; Gabriel SE
    Clin Ther; 2015 Mar; 37(3):660-666.e8. PubMed ID: 25618317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.
    Markenson JA; Gibofsky A; Palmer WR; Keystone EC; Schiff MH; Feng J; Baumgartner SW
    J Rheumatol; 2011 Jul; 38(7):1273-81. PubMed ID: 21572150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada.
    Evans CD; Eurich DT; Lamb DA; Taylor JG; Jorgenson DJ; Semchuk WM; Mansell KD; Blackburn DF
    J Manag Care Pharm; 2009; 15(6):476-84. PubMed ID: 19610680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.